PriceTargets.com logo

IsoPlexis - ISO Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.76 As of 03/21/2023 01:00 AM ET
+0 (0.00%)
Get New IsoPlexis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ISO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISO

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for IsoPlexis in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.76.

This chart shows the closing price for ISO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in IsoPlexis. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2023Morgan StanleyLower TargetEqual Weight$5.00 ➝ $1.70Low
12/22/2022SVB LeerinkLower TargetMarket Perform$2.50 ➝ $1.50Low
11/11/2022SVB LeerinkLower TargetMarket Perform$3.00 ➝ $2.50Low
8/11/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$8.00 ➝ $5.00Low
8/11/2022SVB LeerinkDowngradeOutperform ➝ Market Perform$8.00 ➝ $3.00Low
2/15/2022Morgan StanleyLower TargetOverweight$17.00 ➝ $12.00Low
1/27/2022SVB LeerinkLower TargetOutperform$20.00 ➝ $15.00High
11/19/2021Evercore ISIInitiated CoverageOutperform$24.00Medium
11/11/2021SVB LeerinkBoost TargetOutperform$17.00 ➝ $20.00Medium
11/2/2021SVB LeerinkInitiated CoverageOutperform$17.00High
11/2/2021CowenInitiated CoverageOutperformHigh
11/2/2021Morgan StanleyInitiated CoverageOverweight$16.00High
(Data available from 4/25/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
IsoPlexis logo
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
Read More

Today's Range

Now: $0.76
Low: $0.76
High: $0.76

50 Day Range

MA: $0.86
Low: $0.74
High: $1.13

52 Week Range

Now: $0.76
Low: $0.60
High: $5.10

Volume

N/A

Average Volume

68,375 shs

Market Capitalization

$30.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Frequently Asked Questions

What sell-side analysts currently cover shares of IsoPlexis?

The following sell-side analysts have issued reports on IsoPlexis in the last twelve months:
View the latest analyst ratings for ISO.

What is the current price target for IsoPlexis?

0 Wall Street analysts have set twelve-month price targets for IsoPlexis in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for IsoPlexis in the next year.
View the latest price targets for ISO.

What is the current consensus analyst rating for IsoPlexis?

IsoPlexis currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ISO.

What other companies compete with IsoPlexis?

Other companies that are similar to IsoPlexis include Singular Genomics Systems, Rapid Micro Biosystems, Cue Health, Accelerate Diagnostics and Bionano Genomics. Learn More about companies similar to IsoPlexis.

How do I contact IsoPlexis' investor relations team?

IsoPlexis' physical mailing address is 35 NE INDUSTRIAL ROAD, BRANFORD CT, 06405. The company's listed phone number is 203-208-4111 and its investor relations email address is [email protected]. The official website for IsoPlexis is isoplexis.com. Learn More about contacing IsoPlexis investor relations.